| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: OMPI |
| Security Type |
Common Stock |
| Lead Underwriter |
JP Morgan |
| Days In Registration |
91 |
| Date Filed |
13-Sep-2006 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Obagi Medical Products Inc, located in Long Beach, California, manufactures and wholesales proprietary prescription skin care systems and products. The company offers prescription-based, topical skin health systems that enable physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper-pigmentation, and acne, as well as soft tissue deficits, such as fine lines and wrinkles. The company was founded in 1988. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
21.8M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.35M |
| Secondary Shares Filed | 1.35M |
| · As a Percent |
25.2 |
| Primary Shares Filed |
4.0M |
| · As a Percent |
74.8 |
| Overallotment Shares Filed |
802.5K |
| File Amount |
$74.9M |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
Current Filing Information
(Amended 12-Dec-2006) |
|
US |
|
Shares Filed |
5.35M |
| Secondary Shares Filed |
1.35M |
| · As a Percent |
25.2 |
| Primary Shares Filed |
4.0M |
| · As a Percent |
74.8 |
| Overallotment Shares Filed |
- |
| File Amount |
$74.9M |
| · % Change from Original |
0.0 |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
|
